Dr Mohamed Bouattour
- Specialty
- Onco-hepatology (hepatocellular carcinoma, cholangiocarcinoma, rare liver cancers)
- Hospital
- Hôpital Beaujon (Clichy)
- Latest articles
-
- Sunitinib as Second-Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN-CK GERCOR Phase II Trial. (Aug 1, 2025)
- Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study. (Jun 4, 2025)
- Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study. (May 15, 2025)
- ESR Bridges: imaging and treatment of uncommon liver tumours-a multidisciplinary view. (May 9, 2025)
- Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies. (Feb 4, 2025)